Pfizer Raises Bid for AstraZeneca to $117 Billion

U.S. drugmaker Pfizer said on Sunday it had raised its offer for British rival AstraZeneca to 69.3 billion pounds ($116.6 billion), or 55 pounds a share, and would walk away if AstraZeneca did not accept it. May 19, 2014

HSBC says Bonus for Chairman Capped at 1 Million Pounds

Banking group HSBC Holdings Plc (HSBA.L) has attempted to head off investor criticism over a new pay plan, capping any share bonus for its Chairman Douglas Flint this year at 1 million pounds ($1.7 million) and saying it would be a one off. May 15, 2014

AstraZeneca Leaves Door Ajar to Pfizer, Despite Hurdles

AstraZeneca's boss said on Wednesday he would engage with Pfizer if the price was right and the risks posed from forcing the British drugmaker's operations into the U.S. company's new three-unit model were addressed. May 15, 2014

Ranbaxy Posts Loss after Write-offs on U.S. Import Bans

Drugmaker Ranbaxy Laboratories Ltd (RANB.NS), which has agreed to be acquired by Sun Pharmaceutical Industries Ltd (SUN.NS) for $3.2 billion, posted a loss in the March quarter, hit by write-offs related to regulatory sanctions. May 10, 2014